Scotland's Rx charge cut 20%, to be abolished by 2011

13 April 2009

The government levy on prescription drugs in Scotland has been cut by 20% from GBP5 ($7.40) to GBP4, effective from April, with the commitment of  the Scottish Parliament to abolish the charge altogether by 2011. With  the tax previously scrapped in Wales (Marketletters passim) and due to  be eliminated in Northern Ireland next year, this means that England,  where the prescription charge has risen from GBP7.10 to GBP7.20, is the only  part of the UK where National Health Service patients pay towards their  medicines.

The UK's public broadcaster, the BBC, reports that cancer patients will  be exempt from paying an Rx charge throughout the UK from the current  year, although the lack of provision of newer treatments following a  spate of negative rulings by the National Institute for Health and  Clinical Excellence (NICE) means that patients may have to top up by  paying private sector rates for drugs, a practice which was only made  legal in England late last year (Marketletter November 10, 2008), with  Scotland following in December (Marketletter December 22, 2008).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight